IMMUMEDIC · European information platform for dendritic cell therapy · No promise of cure
Side effects & risks

What side effects and risks can dendritic cell therapy have?

Possible risks depend on the specific cell product, route of administration, accompanying treatments and the patient’s individual condition. Risks and uncertainties should be discussed before treatment.

In brief: This information is intended for orientation and does not replace medical counselling or an individual benefit-risk assessment.

Possible local reactions

Depending on the route of administration, temporary redness, swelling, tenderness or other local reactions may occur at the injection site.

General immune reactions

Fever, chills, fatigue, headache, muscle aches or other inflammatory symptoms may occur. Severity and frequency depend on the procedure and the individual patient.

Infection and product quality

Cell-based procedures require controlled manufacturing, documented quality checks, appropriate transport and correct handling. Product-specific release criteria and instructions from the responsible manufacturing partner are essential.

Interactions with other treatments

Chemotherapy, corticosteroids, immunotherapies, radiotherapy and other treatments can influence immune function, timing and tolerability. The complete treatment plan therefore needs to be considered.

Uncertain effectiveness is also a risk

Even if a procedure is technically feasible and tolerated, clinical benefit cannot be guaranteed. Time, costs and potential delay of other effective treatments must be part of an informed decision.

When medical help is required

New or severe symptoms such as high fever, breathing difficulties, circulatory problems, pronounced allergic symptoms, neurological changes or rapidly worsening general condition require prompt medical assessment.

Editorial context: Risks must always be assessed in relation to the individual patient, the exact cell product and the complete oncological treatment plan. Last structural revision: 19 August 2026.
ORIENTATION

Patient or medical professional?

These two pathways are intentionally separated so that enquiries can be directed appropriately.

Call Rita+49 30 439 792 5331